Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 10, 2016 - Issue
Submit an article Journal homepage
61
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Very rapid virologic response and early HCV response kinetics, as quick measures to compare efficacy and guide a personalized response-guided therapy

Mostafa Yakoot1 Green Clinical Research Center;2 Abbas Helmy ClinicsCorrespondence[email protected]
,
Alaa M Abdo3 Tropical Medicine and Hepatology Department, Alexandria Faculty of Medicine
,
Ahmed Yousry4 Microbiology Department, High Institute of Public Health, Alexandria University;5 Mabarat Asafra Labs
&
Sherine Helmy6 Pharco Corporation, Alexandria, Egypt
Pages 2659-2667 | Published online: 25 Aug 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Christine Hong Ting Yang, Aparna Goel & Aijaz Ahmed. (2018) Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C. Adolescent Health, Medicine and Therapeutics 9, pages 103-110.
Read now

Articles from other publishers (8)

Melda Turken, Sukran Kose, Nadide Colak Ergun & Bengu Tatar. (2020) Rapid virologic response in chronic hepatitis C genotype 1: Evaluation of pretreatment factors in patients. Arab Journal of Gastroenterology 21:4, pages 278-281.
Crossref
Dung Thanh Nguyen, Thanh Thi Thanh Tran, Ngoc My Nghiem, Phuong Thanh Le, Quang Minh Vo, Jeremy Day, Motiur Rahman & Hung Mạnh Le. (2020) Effectiveness of sofosbuvir based direct-acting antiviral regimens for chronic hepatitis C virus genotype 6 patients: Real-world experience in Vietnam. PLOS ONE 15:5, pages e0233446.
Crossref
Mehmet Cabalak, Tayibe Bal, Yusuf Onlen & Mehmet Demir. (2019) Incidence and predictors of direct-acting antiviral treatment failure in Turkish patients with chronic hepatitis C genotype 1b infection. Tropical Doctor 50:2, pages 141-146.
Crossref
Hugo PerazzoRodolfo CastroPaula M LuzMariana BanholiRafaela V GoldenzonSandra W CardosoBeatriz GrinsztejnValdilea G Veloso. (2020) Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis. Bulletin of the World Health Organization 98:3, pages 188-197K.
Crossref
Ankur Gupta, Puneet Arora & Priyanka Jain. (2018) Sofosbuvir Based Regimen in Management of Hepatitis C for Patients With End Stage Renal Disease on Hemodialysis: A Single Center Experience from India. Journal of Clinical and Experimental Hepatology 8:2, pages 116-120.
Crossref
Madhumita Premkumar, Gagandeep S. Grover & Radha K. Dhiman. (2017) Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?. Journal of Clinical and Experimental Hepatology 7:3, pages 253-261.
Crossref
Mostafa Yakoot, Alaa M. Abdo, Siham Abdel-Rehim & Sherine Helmy. (2017) Response Tailored Protocol Versus the Fixed 12 Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial. EBioMedicine 21, pages 182-187.
Crossref
Behzad Hajarizadeh. (2017) Generic Direct Acting Antiviral Treatment: The First Step Towards Elimination of Hepatitis C in Iran. Hepatitis Monthly 17:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.